HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zhongchan Sun Selected Research

norbinaltorphimine

1/2011U50,488H postconditioning reduces apoptosis after myocardial ischemia and reperfusion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zhongchan Sun Research Topics

Disease

5Myocardial Ischemia (Ischemic Heart Diseases)
01/2018 - 01/2011
5Infarction (Infarctions)
01/2016 - 01/2011
5Neoplasms (Cancer)
11/2014 - 07/2013
4Ischemia
01/2017 - 01/2011
4Myocardial Infarction
01/2016 - 01/2013
3Reperfusion Injury
01/2018 - 01/2013
2Inflammation (Inflammations)
01/2017 - 07/2014
1Paraplegia (Spastic Paraplegia)
01/2022
1Stroke (Strokes)
01/2022
1Peripheral Arterial Disease
01/2022
1Pleural Effusion (Pleural Effusions)
01/2018
1Hypoxia (Hypoxemia)
01/2017
1Diabetes Mellitus
01/2017
1Fibrosis (Cirrhosis)
01/2016
1Heart Failure
01/2016
1Hypertrophy
01/2016
1Heart Diseases (Heart Disease)
01/2015
1Stomach Neoplasms (Stomach Cancer)
11/2014
1Neoplasm Metastasis (Metastasis)
12/2013
1Insulinoma
07/2013
1Traumatic Brain Injuries (Traumatic Brain Injury)
06/2013
1B-Cell Lymphoma (Lymphoma, B Cell)
06/2013

Drug/Important Bio-Agent (IBA)

2AlbuminsIBA
01/2022 - 07/2014
2(trans)-Isomer 3,4- Dichloro- N- methyl- N- (2- (1- pyrrolidinyl)- cyclohexyl)- benzeneacetamideIBA
01/2016 - 01/2011
2Exenatide (Byetta)FDA Link
01/2015 - 07/2013
1ZP2495IBA
01/2018
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2017
1Glucose (Dextrose)FDA LinkGeneric
01/2017
1Mechanistic Target of Rapamycin Complex 1IBA
01/2017
1Heme Oxygenase-1IBA
01/2016
1ChloridesIBA
01/2016
1Opioid Analgesics (Opioids)IBA
01/2016
1Evans Blue (Blue, Evans)FDA Link
01/2016
1Glucagon-Like Peptide-1 ReceptorIBA
01/2015
1Glucagon-Like Peptide 1 (GLP 1)IBA
01/2015
1MicroRNAs (MicroRNA)IBA
11/2014
1Pharmaceutical PreparationsIBA
11/2014
1Ethylene Glycol (Monoethylene Glycol)IBA
11/2014
1IronIBA
11/2014
1TurpentineIBA
07/2014
11,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA
04/2014
1IntegrinsIBA
04/2014
1arginyl-glycyl-aspartic acidIBA
04/2014
1Peptides (Polypeptides)IBA
12/2013
1TC14012IBA
12/2013
1Sulfhydryl Compounds (Thiols)IBA
07/2013
1Glucagon-Like Peptides (Enteroglucagon)IBA
07/2013
1Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA
06/2013
1Nerve Growth Factor (NGF)IBA
06/2013
1bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA
06/2013
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
06/2013
1Histone Deacetylase InhibitorsIBA
06/2013
1Insulin (Novolin)FDA Link
05/2013
1Thioctic Acid (Lipoic Acid)IBA
01/2013
1WortmanninIBA
01/2011
1norbinaltorphimineIBA
01/2011
1NG-Nitroarginine Methyl Ester (L-NAME)IBA
01/2011
1Nitric Oxide Synthase (NO Synthase)IBA
01/2011
1Opioid Receptors (Opioid Receptor)IBA
01/2011
1Phosphatidylinositols (Phosphatidylinositol)IBA
01/2011

Therapy/Procedure

2Therapeutics
01/2017 - 11/2014
2Drug Therapy (Chemotherapy)
11/2014 - 12/2013
1Tracheostomy
01/2022
1Length of Stay
01/2018
1Intraperitoneal Injections
11/2014